Anxiety and substance use disorder comorbidity: Prevalence, explanatory models and treatment implications

Journal of Dual Diagnosis

Volumn 2, Issue 4, 2006, Pages 93-119

  Wyman, Katie ^a   Castle, David J ^a,b,c  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Anxiety disorders; Comorbidity; Dual disorders; Substance use disorders; Treatment

Indexed keywords

ANXIETY DISORDER; COMORBIDITY; DETOXIFICATION; DISEASE ASSOCIATION; DRUG DEPENDENCE; EXPLANATORY VARIABLE; HUMAN; PREVALENCE; REVIEW; RISK ASSESSMENT; SOCIAL PHOBIA; SUBSTANCE ABUSE; TREATMENT PLANNING;

EID: 33748464524     PISSN: 15504263     EISSN: 15504271     Source Type: Journal    
DOI: 10.1300/J374v02n04_07     Document Type: Review

References (76)

1. Grant B, Stinson F, Dawson D, Chou P, Dufour M et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders. Achieves of General Psychiatry 2004; 61: 807-816
2. Regier D, Rae D, Narrow W, Kaelber C, Schatzberg A. Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. British Journal of Psychiatry 1998; 173: 24-28
3. Creamer M, Burgess P, McFarlane AC. Post-traumatic stress disorder: Findings from the Australian National Survey of Mental Health and Well-being. Psychological Medicine 2001; 31: 1237-1247
4. Kushner M, Sher K. The relation between alcohol problems and the anxiety disorders. American Journal of Psychiatry 1990; 147: 685-695
5. Ramirez J. Chemical addictions and anxiety disorders: When adaptive mechanisms go awry. In: O'Connell D, Beyer E, eds. Managing the Dually Diagnosed Patient: Clinical Issues and Clinical Approaches: 2 Edition. New York: The Hawthorn Press, 2002; 239-286
6. Mueser KT, Noordsky DL, Drake RE, Fox L. Integrated Treatment for dual disorders: A guide to effective practice. New York: The Guilford Press, 2003
7. Kushner M, Thuras P, Abrams L, Brekke M, L S. Anxiety mediates the association between anxiety sensitivity and coping-related drinking motives in alcoholism treatment patients. Addictive Behaviors 2001; 26: 869-885
8. DeHass RA, Calamari JE, Bair JP, Martin ED. Anxiety sensitivity and drug or alcohol use in individuals with anxiety and substance use disorders. Addictive Behaviors 2001; 26: 787-801
9. Khantzian EJ. The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. American Journal of Psychiatry 1985; 142: 1259-1264
10. Jacobsen L, Southwick S, Kosten T. Substance use disorders in patients with posttraumatic stress disorder: A review of the literature. American Journal of Psychiatry 2001; 158: 1184-1189
11. Lepine J-P, Pelissolo A. Social phobia and alcoholism: A complex relationship. Journal of Affective Disorders 1998; 50: S23-S28
12. Kushner M, Abrams K, Borchardt C. The relationship between anxiety disorders and alcohol use disorders: A review of major perspectives and findings. Clinical Psychology Review 2000; 2: 149-171
13. Chambless DL, Cherney J, Caputo GC, Rheinstein BJG. Anxiety disorders and alcoholism: Astudy with inpatient alcoholics. Journal of Anxiety Disorders 1987; 1: 29-40
14. Thomas SE, Randall CL, Carrigan MH. Drinking to cope in socially anxious individuals: A controlled study. Alcoholism: Clinical and Experimental Research 2003; 27: 1937-1943
15. Malan JR, Norton GR, Cox BJ. Panic Attacks and Alcoholism: Primacy and Frequency of Attacks. Alcoholism Treatment Quarterly 1993; 1993: 95-105
16. Cox BJ, Norton R, Dorward J, Fergusson PA. The relationship between panic attacks and chemical dependency. Addictive Behaviors 1989; 14: 319-328
17. Sbrana A, Bizzarri J, Rucci P, Gonnelli C, Doria M, Spagnolli S, Ravani L, Raimondi F, Dell'Osso L, Cassano G. The spectrum of substance use in mood and anxiety disorders. Comprehensive Psychiatry 2005; 46: 6-13
18. Gruber AJ, Pope HG, Olian P. Very long term use of marijuana in the United States: A Pilot Study. Substance Use and Misuse 1997; 32: 249-264
19. Stewart S, Conrad P. Psychosocial models of functional associations between posttraumatic stress disorder and substance use disorder. In: Ouimette P, Brown PJ, eds. Trauma and substance abuse: Causes, consequences and treatment of comorbid disorders. Washington: APA, 2003; 29-56
20. Morris EP, Stewart SH, Ham LS. The relationship between social anxiety disorder and alcohol use disorders: A critical review. Clinical Psychology Review 2005; 25: 734-760
21. Myrick H, Brady K. Social phobia in Cocaine-Dependent Individuals. The American Journal on Addictions 1997; 6: 99-104
22. Goldenburg I, Mueller T, Fierman J, Gordon A, Pratt L et al. Specificity of substance use in anxiety-disordered subjects. Comprehensive Psychiatry 1995; 36: 319-328
23. Conrod PJ, Pihl RO, Stewart SH, Dongier M. Validation of a system of classifying female substance abusers on the basis of personality and motivational risk factors for substance abuse. Psychology of Addictive Behaviours 2000; 14: 243-256
24. Castle DJ, Solowij N. Acute and subacute psychomimetic effects of cannabis in humans. In: Castle D, Murray R, eds. Marijuana and Madness. Cambridge: Cambridge University Press, 2004
25. Ghose H. Drugs and addictive behaviour. Cambridge: Cambridge University Press, 2002
26. Watkins K, Hunter S, Burnam A, Pincus H, Nicholson G. Review of treatment recommendations for persons with a co-occuring affective or anxiety and substance use disorder. Psychiatric Services 2005; 56: 913-926
27. Samet S, Nunes EV, Hasin D. Diagnosing comorbidity: Concepts, criteria, and methods. Acta Neuropsychiatrica 2005; 16: 9-18
28. Miltenberger RG. Behavior modification: Principles and procedures: 3rd Edition. CA: Brooks/Cole, 2004
29. McLellan TA, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic intrument for substance abuse patients: The Addiction Severity Index. Journal of Nervous and Mental Disease 1980; 168: 26-33
30. Gavin DR, Ross HE, Skinner HA. Diagnostic validity of the Drug Abuse Screening Test in the assessment of DSM-III drug disorders. British Journal of Addiction 1989; 84: 301-307
31. Dawe S, Loxton NJ, Hides L, Kavanagh DJ, Mattick RP. Review of diagnostic screening instruments for alcohol and other drug use and other psychiatric disorders: 2 Edition: Publications Production Unit, Commonwealth Department of Health and Aging, 2002
32. Gossip M, Darke S, Griffiths P, Hando J, Powis B, Hall W, JS. The severity of dependence scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995; 90: 607-614
33. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the alcohol used disorders identification test (AUDIT). WHO collaborative project on early detection of persons with harmful alcohol consumption - II. Addiction 1993; 88: 791-804
34. Raistrick D, Dunbar G, Davidson R. Development of a questionnaire to measure alcohol dependence. Addiction 1983; 78: 89-95
35. McConnaughy EA, Prochaska JO, Velicer WF. Stages of change in psychotherapy: Measurement and sample profiles. Psychotherapy: Theory, Research and Practice 1983; 20: 368-375
36. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology 1988; 56: 893-897
37. Hodgson RJ, Rachman S. Obsessive compulsive complaints. Behaviour Research and Therapy 1977; 10: 181-189
38. Marks IM, Mathews AM. Brief standard self-rating for phobic patients. Behaviour Research and Therapy 1979; 17: 263-267
39. Wells A. A multidimensional measure of worry: Development and preliminary validation of the Anxious Thoughts Inventory. Anxiety stress and coping 1994; 6: 289-299
40. Watson D, Friend R. Measurement of social-evaluative anxiety. Journal of Consulting and Clinical Psychology 1969; 33: 448-457
41. Antony MM, Orsillo SM, Roemer L. Practitioner's guide to empirically-based measures of anxiety. New York: Kluwer Academic/Plenum, 2001
42. Brown TA, Di Nardo PA, Barlow DH. Anxiety disorders interview schedule for DSM-IV (ADIS-IV). New York: Graywind Publications, 1994
43. Marshall JR. Alcohol and substance abuse in panic disorder. Journal of Clinical Psychiatry 1997; 58: 46-49
44. Anthenelli R, Schuckit M. Affective and anxiety disorders and alcohol and drug dependence: Diagnosis and treatment. Journal of Addictive Diseases 1993; 12: 73-87
45. Kadden RM, Kranzler HR, Rounsaville BJ. Validity of the distinction between substance-induced and independent depression and anxiety disorders. The American Journal of Addictions 1995; 4: 107-117
46. Myrick H, Brady K. Current review of the comorbidity of affective, anxiety, and substance use disorders. Current Opinion in Psychiatry 2003; 16: 261-270
47. Dunner D. Management of anxiety disorders: The added challenge of comorbidity. Depression and Anxiety 2001; 13: 57-71
48. Dimitriou E, Lavrentiadis G, Dimitriou C. Obsessive-compulsive disorder and alcohol abuse. European Journal of Psychiatry 1993; 7: 244-248
49. Lehman C, Brown T, Barlow DH. Effects of cognitive-behavioral treatment for panic with agoraphobia on concurrent alcohol abuse. Behaviour Therapy 1998; 29: 423-433
50. Ouimette P, Ahrens C, Moos R, Finney J. Posttraumatic stress disorder in substance abuse patients: Relationship to 1-year posttreatment outcomes. Psychology of Addictive Behaviours 1997; 11: 34-47
51. Ouimette PO, Ahrens C, Moos RH, Finney JW. During treatment changes in substance abuse patients with posttraumatic stress disorder. Journal of Substance Abuse Treatment 1998; 1998
52. Ouimette P, Finney J, Moos R. Two year posttreatment functioning and coping of substance abuse patients with posttraumatic stress disorder. Psychology of Addictive Behaviours 1999; 13: 105-114
53. Brown P. Outcome in female patients with both substance use and post-traumatic stress disorders. Alcoholism Treatment Quarterly 2000; 18: 127-135
54. Brown P, Stout R, Mueller T. Posttraumatic stress disorder and substance abuse relapse among women: A pilot study. Psychology of Addictive Behaviours 1996; 10: 124-128
55. Kushner MG, Abrams K, Thuras P, Hanson KL, Brekke M, Sletten S. Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients. Alcoholism: Clinical and Experimental Research 2005; 29: 1432-1443
56. Driessen M, Meier S, Hill A, Wetterling T, Lange W, Junghanns K. The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol and Alcoholism 2001; 36: 249-255
57. Tomasson K, Vaglum P. The role of psychiatric comorbidity in the prediction of readmission for detoxification. Comprehensive Psychiatry 1998; 39: 129-136
58. Compton W, Cottler L, Jacobs J, Ben-Abdallah A, Spitznagel E. The role of psychiatric disorders in predicting drug dependence treatment outcomes. American Journal of Psychiatry 2003; 160: 890-895
59. LaBounty LP, Hatsukami D, Morganm SF, Nelson L. Relapse among alcoholics with phobic and panic symptoms. Addictive Behaviors 1992; 17: 9-15
60. Thevos AK, Roberts JS, Thomas SE, Randall CR. Cognitive behavioural therapy delays relapse in female socially phobic alcoholics. Addictive Behaviors 2000; 25: 333-345
61. Pincus J, Ramirez J. Dual Diagnosis: Issues in the treatment of comorbid mental health and substance abuse disorders. In: VanderCreek L, Knapp S, Jackson TL, eds. Innovations in Clinical Practice: A source book volume 15, 1997; 71-81
62. Triffleman E. Gender differences in a controlled pilot study of psychosocial treatments in substance dependent patients with post-traumatic stress disorder: Design considerations and outcomes. Alcoholism Treatment Quarterly 2000; 18: 113-126
63. Najavits LM, Weiss RD, Shaw SR, Muenz LR. "Seeking Safety" outcome of a new cognitive behavioural psychotherapy for women with posttraumatic stress disorder and substance dependence. Journal of Traumatic Stress 1998; 11: 437-456
64. Zlotnick C, Najavits LM, Rohsenow D, Johnson DM. A cognitive-behavioural treatment for incarcerated women with substance abuse disorder and posttraumatic stress disorder: Findings from a pilot study. Journal of Substance Abuse Treatment 2003; 25: 99-105
65. Brady KT, Dansky BS, Back SE, Foa E, Carroll K. Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: Preliminary findings. Journal of Substance Abuse Treatment 2001; 21: 47-54
66. Donovan B, Padin-Rivera E, Kowaliw S. "Transcend": Initial outcomes from a posttraumatic stress disorder/substance abuse treatment program. Journal of Traumatic Stress 2001; 14: 757-772
67. Bowen RC, D'Arcy C, Keehan D, Senthilselvan A. A controlled trial of cognitive behavioural treatment of panic in alcoholic inpatients with comorbid panic disorder. Addictive Behaviors 2000; 25: 593-597
68. Randall CL, Thomas S, Thevos AK. Concurrent alcoholism and social anxiety disorders: A first step toward developing effective treatments. Alcoholism: Clinical and Experimental Research 2001; 25: 210-220
69. Fals-Stewart W, Schafer J. The treatment of substance abusers diagnosed with obsessive-compulsive disorder: An outcome study. Journal of Substance Abuse Treatment 1992; 9: 365-370
70. Weiss RD, Najavits LM. Overview of treatment modalities for dual diagnosis patients: Pharmacotherapy, psychotherapy and 12-step programs. In: Kranzler HR, Rounsaville BJ, eds. Dual Diagnosis and Treatment. New York: Marcel Dekker, 1998; 87-107
71. Roth A, Fonagy P. What works for whom: A critical review of psychotherapy research. New York: The Guilford Press, 2005
72. Prochaska JO, DiClemente CC. The transtheoretical approach: Crossing traditional boundaries of therapy. Homewood, IL: Dow Jones/Irwin, 1984
73. Osher FC, Koefoed LL. Treatment of patients with psychiatric and psychoactive substance use disorders. Hospital and Community Psychiatry 1989; 40: 1025-1030
74. Horvath AO, Bedi RP. The Alliance. In: Norcross JC, ed. Psychotherapy relationships that work. New York: Oxford University Press, 2002; 37-70
75. Coffey SF, Dansky BS, Brady KT. Exposure based, trauma-focused therapy for comorbid posttraumatic stress disorder-substance use disorder. In: Ouimette P, Brown P, eds. Trauma and substance abuse: Causes, consequences and treatment of comorbid disorders. Washington: APA, 2003; 127-146
76. Tomasson K, Vaglum P. The 2-year course following detoxification treatment of substance abuse: The possible influence of psychiatric comorbidity. European Archives of Clinical Neuroscience 1997; 247: 320-327